Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PASTIS: Tadalafil in Small Vessel Disease
NCT02450253Phase 2Completed
- Sponsor
- St George's, University of London
- Start
- Sep 2015
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tadalafil in Cerebral Small Vessel Disease (CSVD), sponsored by St George's, University of London. Started Sep 2015; status: completed.
02
Drugs
tadalafil
03
Conditions
Cerebral Small Vessel Disease (CSVD)
Beyond the preview
Go deeper on NCT02450253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02450253.